Haiming Wei

22.5k citations
311 papers · 16.1k · 4 hit papers · h-index 63

Impact in

  • Immunology top 0.1%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Reproductive System and Pregnancy
    • IL-33, ST2, and ILC Pathways
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Immune Cell Function and Interaction 171
    • T-cell and B-cell Immunology 68
    • Reproductive System and Pregnancy 39
    • Immunotherapy and Immune Responses 27
    • IL-33, ST2, and ILC Pathways 27
    • Immune Response and Inflammation 20
    • Hepatitis B Virus Studies 30

Haiming Wei

304 papers receiving 15.8k citations

Haiming Wei's Hit Papers

SIRT3 ‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth 2023 · 152 citations
1520+2+5Years since publication50010001.5k

Peers

Haiming Wei
Comparison fields: 5 of 157
  • Immunology 8.6k
  • Infectious Diseases 3.0k
  • Hepatology 1.2k
  • Oncology 3.2k
  • Obstetrics and Gynecology 810
Replace Rui Sun with:
Rui Sun China
Cecília Garlanda Italy
Paul E. Swanson United States
Ka‐Fai To Hong Kong
Howard A. Young United States
Kate Schroder Australia
Niels Borregaard Denmark
Georges E. Grau Australia
Charles T. Esmon United States
Peter E. Lipsky United States
Haiming Wei relative to Rui Sun China Rui Sun's profile →
Citations per field
00.5×1.5×2.2×
Rui Sun · 1×
Citations per year

Countries citing papers authored by Haiming Wei

Since Specialization
Citations

This map shows the geographic impact of Haiming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiming Wei more than expected).

Fields of papers citing papers by Haiming Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiming Wei. The network helps show where Haiming Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Haiming Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haiming Wei Line = papers co-authored together Haiming Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 311 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effective treatment of severe COVID-19 patients with tocilizumab
Hit paper breakdown →
20201874
2
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Hit paper breakdown →
2020814
3
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Hit paper breakdown →
2018813
4 2013431
5 2014366
6 2018276
7 2017240
8 2012238
9 2018218
10 2017215
11 2016214
12 2002208
13 2019207
14 2013183
15 2012165
16 2012158
17 2011156
18 2013156
19
SIRT3 ‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth
Hit paper breakdown →
2023152
20 2021151

About Haiming Wei

Haiming Wei is a scholar working on Immunology, Epidemiology, Molecular Biology, Oncology and Cancer Research, having authored 311 papers that have together received 16.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (171 papers), T-cell and B-cell Immunology (68 papers), Reproductive System and Pregnancy (39 papers), Hepatitis B Virus Studies (30 papers), Immunotherapy and Immune Responses (27 papers), IL-33, ST2, and ILC Pathways (27 papers), CAR-T cell therapy research (23 papers) and Immune Response and Inflammation (20 papers). The work is most often cited by research in Immunology (8.6k citations), Infectious Diseases (3.0k citations), Hepatology (1.2k citations), Oncology (3.2k citations) and Obstetrics and Gynecology (810 citations). Haiming Wei has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Zhigang Tian, Rui Sun, Binqing Fu, Xiaohu Zheng, Yonggang Zhou, Yongyan Chen, Xiaoling Xu, Xiaodong Zheng, Hui Peng and Zhongjun Dong. Their work appears in journals such as Frontiers in Immunology, Hepatology, The Journal of Immunology, International Immunopharmacology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact